세계의 뇌졸중 시장 보고서(2025년)

Stroke Global Market Report 2025

US $ 4,490 ￦ 6,457,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,334,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 12,211,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 뇌졸중 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년까지 CAGR 10.3%로 확대되어 588억 1,000만 달러로 성장할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 원격 의료 이용 증가, 저침습 치료에 대한 수요 증가, 조기 진단의 중시, 신흥 시장의 건강 관리 접근 확대, 뇌졸중 관리 기술 투자 증가로 이어집니다. 주요 동향으로는 AI를 활용한 진단 툴의 발전, 신경 재활에서 기술 혁신의 진행, 새로운 혈전 용해제의 개발, 개별화 뇌졸중 치료 어프로치, 재생 치료 연구의 진전 등이 예상됩니다.

고혈압 사례 증가는 향후 수년간 뇌졸중 시장의 성장을 이끌 것으로 예측됩니다. 고혈압은 동맥 벽에 대한 혈액의 힘이 일관되게 상승한 채로 남아있을 때 발생합니다. 고혈압 증례 증가는 비만률의 상승이 주요 원인이며, 과도한 체중이 심장과 혈관에 추가적인 부담을 주어 장기간의 혈압 상승으로 이어지기 때문입니다. 고혈압은 혈관벽에 과도한 압력을 가하여 뇌졸중을 조장하여 뇌의 동맥이 약해지거나 좁아지거나 파열될 수 있습니다. 예를 들어, 2025년 1월 미국 비영리 단체인 미국 심장협회(American Heart Association)는 2022년 고혈압을 주요 원인으로 하는 사망자 수 13만 1,454명을 보고했습니다. 또한 2024년 1월에는 이 단체가 2021년 고혈압을 주요 원인으로 하는 사망자 수를 12만 4,508명으로 보고하고 있습니다. 따라서 고혈압의 유병률 증가는 뇌졸중 시장 확대에 박차를 가하고 있습니다.

뇌졸중 시장의 주요 기업은 기계적 혈전 제거술과 같은 복잡한 신경혈관 치료에서 절차의 정확성과 치료 성적을 향상시키기 위해 유량 조절식 대구경 접근 장치와 같은 혁신적인 뇌졸중 중재 기술에 주력하고 있습니다. 유량 조절식 대구경 접근장치는 장치 전달을 위한 넓은 내경과 통합된 혈류 제어를 결합한 카테터 설계를 포함하여 신경혈관 치료 중 보다 안전하고 효과적인 네비게이션을 가능하게 합니다. 예를 들어 2025년 2월 미국 의료기술 기업인 Johnson & Johnson MedTech은 급성 허혈에 대한 기계적 혈전 제거술 시 접근 및 혈류 조절을 강화하기 위해 고안된 차세대 .092인치 카테터인 CEREGLIDE 92 Catheter System을 발표했습니다. 이 시스템은 의사가 뇌의 해부학적 구조를 탐색하고 보다 효율적으로 혈류를 회복하도록 돕습니다. 이 시스템은 부드러운 카테터 삽입을 가능하게 하는 INNERGLIDE 9 딜리버리 에이드와 절차 중 시인성을 향상시키는 BRITE-LINE 기술을 탑재하고 있습니다. TruCourse 연질 칩은 복잡한 뇌 혈관의 네비게이션을 촉진하고 치료 성공과 환자의 예후를 향상시킵니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 뇌졸중 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 뇌졸중 시장 : 성장률 분석
• 세계의 뇌졸중 시장 실적 : 규모와 성장, 2019-2024년
• 세계의 뇌졸중 시장 예측 : 규모와 성장, 2024-2029년, 2034년
• 세계의 뇌졸중 시장 : 총 시장 규모(TAM)

제6장 시장 세분화

• 세계의 뇌졸중 시장 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 허혈성 뇌졸중
• 일과성 뇌허혈 발작(TIA)
• 출혈성 뇌졸중
• 세계의 뇌졸중 시장 : 진단 및 치료별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 진단
• 치료
• 세계의 뇌졸중 시장 : 성별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 여성
• 남성
• 세계의 뇌졸중 시장 : 유통 채널별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 직접
• 소매
• 온라인
• 세계의 뇌졸중 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 병원
• 클리닉
• 세계의 뇌졸중 시장 : 허혈성 뇌졸중별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 혈전성 뇌졸중
• 색전성 뇌졸중
• 원인불명 뇌졸중
• 열공 뇌졸중
• 세계의 뇌졸중 시장 : 일과성 뇌허혈 발작(TIA)의별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 경동맥 일과성 허혈 발작(TIA)
• 심장 기원 일시적인 허혈 발작(TIA)
• 원인 불명 일과성 뇌허혈 발작(TIA)
• 세계의 뇌졸중 시장 : 출혈성 뇌졸중별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 뇌내 출혈(ICH)
• 지주막하 출혈(SAH)
• 경막하 출혈
• 경막외 출혈

제7장 지역별/국가별 분석

• 세계의 뇌졸중 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 뇌졸중 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 뇌졸중 시장 : 경쟁 구도
• 뇌졸중 시장 : 기업 프로파일
  • Pfizer Inc.
  • Johnson & Johnson Services Inc.
  • F. Hoffmann-La Roche Ltd.
  • Bayer AG
  • Sanofi SA

제31장 기타 주요 기업 및 혁신 기업

• Bristol-Myers Squibb Company
• AstraZeneca plc
• Abbott Laboratories
• Medtronic plc
• Fresenius SE & Co. KGaA
• Stryker Corporation
• Boehringer Ingelheim International GmbH
• Viatris Inc.
• Teva Pharmaceuticals USA Inc.
• Daiichi Sankyo Company Limited
• Amneal Pharmaceuticals LLC
• Lupin Limited
• MicroPort Scientific Corporation
• Penumbra Inc.
• NeuroVasc Technologies Inc.

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

• 뇌졸중 시장(2029년) : 새로운 기회를 제공하는 국가
• 뇌졸중 시장(2029년) : 새로운 기회를 제공하는 부문
• 뇌졸중 시장(2029년) : 성장 전략
  • 시장 동향에 의한 전략
  • 경쟁 전략

제36장 부록

JHS

영문 목차

영문목차

Stroke is a severe medical emergency caused by a blockage or reduction in blood flow to a portion of the brain, which prevents the delivery of vital oxygen and nutrients to brain tissue. This interruption can cause brain cells to die within minutes, leading to sudden impairments like speech difficulties, paralysis, or cognitive dysfunction, and may result in lasting disability or death if immediate treatment is not administered.

The primary types of stroke include ischemic stroke, transient ischemic attack (TIA), and hemorrhagic stroke. Ischemic stroke occurs when a blood clot or other blockage obstructs blood flow to the brain, cutting off oxygen and nutrients. Various diagnoses and treatments are tailored for different gender groups, including male and female patients, and these services are distributed through channels such as direct providers, retail outlets, and online platforms. The main users of these services are hospitals and clinics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The stroke market research report is one of a series of new reports from The Business Research Company that provides stroke market statistics, including the stroke industry global market size, regional shares, competitors with the stroke market share, detailed stroke market segments, market trends, and opportunities, and any further data you may need to thrive in the stroke industry. This stroke market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The stroke market size has grown rapidly in recent years. It will grow from $35.92 billion in 2024 to $39.72 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth during the historical period is driven by the rising prevalence of cardiovascular diseases, an expanding elderly population, improved awareness of stroke symptoms, development of hospital infrastructure, and enhanced government support initiatives.

The stroke market size is expected to see rapid growth in the next few years. It will grow to $58.81 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The anticipated growth during the forecast period is driven by the increasing use of telemedicine, rising demand for minimally invasive treatments, greater emphasis on early diagnosis, expanding healthcare access in emerging markets, and growing investment in stroke care technologies. Key trends expected include advancements in AI-powered diagnostic tools, ongoing innovations in neurorehabilitation, development of new thrombolytic medications, personalized stroke treatment approaches, and progress in regenerative therapy research.

The rising number of hypertension cases is expected to drive the growth of the stroke market in the coming years. Hypertension, or high blood pressure, occurs when the force of blood against artery walls remains consistently elevated. The increase in hypertension cases is largely attributed to rising obesity rates, as excess body weight puts additional strain on the heart and blood vessels, leading to higher blood pressure over time. Hypertension contributes to stroke by placing excessive pressure on blood vessel walls, which can result in the weakening, narrowing, or rupture of arteries in the brain. For example, in January 2025, the American Heart Association, a US-based nonprofit, reported 131,454 deaths primarily linked to high blood pressure in 2022. Additionally, in January 2024, the same organization reported 124,508 deaths primarily related to high blood pressure in 2021. Thus, the growing prevalence of hypertension is fueling the expansion of the stroke market.

Key players in the stroke market are concentrating on innovative stroke intervention technologies, such as flow-regulated large-bore access devices, to improve procedural accuracy and outcomes in complex neurovascular treatments like mechanical thrombectomy. Flow-regulated large-bore access involves a catheter design that combines a wide inner diameter for device delivery with integrated blood flow control, allowing for safer and more effective navigation during neurovascular procedures. For instance, in February 2025, Johnson & Johnson MedTech, a US-based medical technology firm, introduced the CEREGLIDE 92 Catheter System, a next-generation.092" catheter designed to enhance access and flow regulation during mechanical thrombectomy for acute ischemic stroke. This system aids physicians in navigating brain anatomy and restoring blood flow more efficiently. The device includes the INNERGLIDE 9 delivery aid for smooth catheter insertion and BRITE-LINE technology for improved visibility during procedures. Its TruCourse flexible tip facilitates navigation through complex cerebral vessels, boosting treatment success and patient outcomes, while also promoting sustainability through electronic instructions, reducing environmental impact.

In May 2025, Merck KGaA, a US-based science and technology company, acquired ApTOLL from aptaTargets for an undisclosed sum. Through this acquisition, Merck KGaA aims to broaden its neurology portfolio by advancing the development and commercialization of ApTOLL, an innovative therapy targeting acute ischemic stroke with the potential to reduce inflammation and brain damage, thereby improving patient outcomes. AptaTargets SL is a Spain-based biotechnology firm focused on developing novel treatments for acute neurological conditions, especially acute ischemic stroke.

Major players in the stroke market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Medtronic plc, Fresenius SE & Co. KGaA, Stryker Corporation, Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceuticals USA Inc., Daiichi Sankyo Company Limited, Amneal Pharmaceuticals LLC, Lupin Limited, MicroPort Scientific Corporation, Penumbra Inc., and NeuroVasc Technologies Inc.

North America was the largest region in the stroke market in 2024, and it is expected to be the fastest-growing region in the forecast period. The regions covered in stroke report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the stroke market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The stroke market includes revenues earned by entities by providing services such as emergency medical services, imaging services, and blood pressure management. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Stroke Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on stroke market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for stroke ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The stroke market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Ischemic Stroke; Transient Ischemic Attack (TIA); Hemorrhagic Stroke
• 2) By Diagnosis And Treatment: Diagnosis; Treatment
• 3) By Gender: Female; Male
• 4) By Distribution Channel: Direct; Retail; Online
• 5) By End User: Hospitals; Clinics
• Subsegments:
• 1) By Ischemic Stroke: Thrombotic Stroke; Embolic Stroke; Cryptogenic Stroke; Lacunar Stroke
• 2) By Transient Ischemic Attack (TIA): Carotid Artery Transient Ischemic Attack (TIA); Cardiac Source Transient Ischemic Attack (TIA); Undetermined Cause Transient Ischemic Attack (TIA)
• 3) By Hemorrhagic Stroke: Intracerebral Hemorrhage (ICH); Subarachnoid Hemorrhage (SAH); Subdural Hemorrhage; Epidural Hemorrhage
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; Bayer AG; Sanofi S.A.; Bristol-Myers Squibb Company; AstraZeneca plc; Abbott Laboratories; Medtronic plc; Fresenius SE & Co. KGaA; Stryker Corporation; Boehringer Ingelheim International GmbH; Viatris Inc.; Teva Pharmaceuticals USA Inc.; Daiichi Sankyo Company Limited; Amneal Pharmaceuticals LLC; Lupin Limited; MicroPort Scientific Corporation; Penumbra Inc.; NeuroVasc Technologies Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Stroke Market Characteristics

3. Stroke Market Trends And Strategies

4. Stroke Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Stroke Growth Analysis And Strategic Analysis Framework

• 5.1. Global Stroke PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Stroke Market Growth Rate Analysis
• 5.4. Global Stroke Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Stroke Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Stroke Total Addressable Market (TAM)

6. Stroke Market Segmentation

• 6.1. Global Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ischemic Stroke
• Transient Ischemic Attack (TIA)
• Hemorrhagic Stroke
• 6.2. Global Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnosis
• Treatment
• 6.3. Global Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Female
• Male
• 6.4. Global Stroke Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct
• Retail
• Online
• 6.5. Global Stroke Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• 6.6. Global Stroke Market, Sub-Segmentation Of Ischemic Stroke, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Thrombotic Stroke
• Embolic Stroke
• Cryptogenic Stroke
• Lacunar Stroke
• 6.7. Global Stroke Market, Sub-Segmentation Of Transient Ischemic Attack (TIA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Carotid Artery Transient Ischemic Attack (TIA)
• Cardiac Source Transient Ischemic Attack (TIA)
• Undetermined Cause Transient Ischemic Attack (TIA)
• 6.8. Global Stroke Market, Sub-Segmentation Of Hemorrhagic Stroke, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intracerebral Hemorrhage (ICH)
• Subarachnoid Hemorrhage (SAH)
• Subdural Hemorrhage
• Epidural Hemorrhage

7. Stroke Market Regional And Country Analysis

• 7.1. Global Stroke Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Stroke Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Stroke Market

• 8.1. Asia-Pacific Stroke Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Stroke Market

• 9.1. China Stroke Market Overview
• 9.2. China Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Stroke Market

• 10.1. India Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Stroke Market

• 11.1. Japan Stroke Market Overview
• 11.2. Japan Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Stroke Market

• 12.1. Australia Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Stroke Market

• 13.1. Indonesia Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Stroke Market

• 14.1. South Korea Stroke Market Overview
• 14.2. South Korea Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Stroke Market

• 15.1. Western Europe Stroke Market Overview
• 15.2. Western Europe Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Stroke Market

• 16.1. UK Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Stroke Market

• 17.1. Germany Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Stroke Market

• 18.1. France Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Stroke Market

• 19.1. Italy Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Stroke Market

• 20.1. Spain Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Stroke Market

• 21.1. Eastern Europe Stroke Market Overview
• 21.2. Eastern Europe Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Stroke Market

• 22.1. Russia Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Stroke Market

• 23.1. North America Stroke Market Overview
• 23.2. North America Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Stroke Market

• 24.1. USA Stroke Market Overview
• 24.2. USA Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Stroke Market

• 25.1. Canada Stroke Market Overview
• 25.2. Canada Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Stroke Market

• 26.1. South America Stroke Market Overview
• 26.2. South America Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Stroke Market

• 27.1. Brazil Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Stroke Market

• 28.1. Middle East Stroke Market Overview
• 28.2. Middle East Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Stroke Market

• 29.1. Africa Stroke Market Overview
• 29.2. Africa Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Stroke Market Competitive Landscape And Company Profiles

• 30.1. Stroke Market Competitive Landscape
• 30.2. Stroke Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Stroke Market Other Major And Innovative Companies

• 31.1. Bristol-Myers Squibb Company
• 31.2. AstraZeneca plc
• 31.3. Abbott Laboratories
• 31.4. Medtronic plc
• 31.5. Fresenius SE & Co. KGaA
• 31.6. Stryker Corporation
• 31.7. Boehringer Ingelheim International GmbH
• 31.8. Viatris Inc.
• 31.9. Teva Pharmaceuticals USA Inc.
• 31.10. Daiichi Sankyo Company Limited
• 31.11. Amneal Pharmaceuticals LLC
• 31.12. Lupin Limited
• 31.13. MicroPort Scientific Corporation
• 31.14. Penumbra Inc.
• 31.15. NeuroVasc Technologies Inc.

32. Global Stroke Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Stroke Market

34. Recent Developments In The Stroke Market

35. Stroke Market High Potential Countries, Segments and Strategies

• 35.1 Stroke Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Stroke Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Stroke Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료